greeksoup/ stock research
Stock research / United States / Funds / Bellevue Group AG

Bellevue Group AG

CIK 1674546 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Bellevue Group AG reported 148 US-listed holdings worth $4.75 billion in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: Amgen Inc. (6.5%), Vertex Pharmaceuticals Inc. (6.0%) and argenx SE (5.9%). Against the quarter before, it opened 17 positions, added to 39, trimmed 65 and sold out of 24.

Reported holdings$4.75B+13.1% on Q1 2026
Positions148-7 on Q1 2026
The largest ten42.9%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
Added toHeldTrimmed
AMGN6.5%VRTX6.0%ARGX5.9%GILD5.7%RVMD4.1%ORKA3.3%INSM3.1%SRRK2.8%NUVL2.7%VRDN2.6%RLAY2.4%PCVX2.4%UTHR2.1%ISRG2.1%134 more48.0%

The 14 largest of its 148 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $6.17 billion in 162 positions$6.17BQ3 24Q4 2024: $5.19 billion in 160 positions$5.19BQ4 24Q1 2025: $4.46 billion in 148 positions$4.46BQ1 25Q2 2025: $4.54 billion in 142 positions$4.54BQ2 25Q3 2025: $4.81 billion in 148 positions$4.81BQ3 25Q4 2025: $5.28 billion in 176 positions$5.28BQ4 25Q1 2026: $4.20 billion in 155 positions$4.20BQ1 26Q2 2026: $4.75 billion in 148 positions$4.75BQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What it did on the quarter

Opened 17Added 39Held 27Trimmed 65Sold out 24
Opened: 17Added: 39Held: 27Trimmed: 65Sold out: 24

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Opened 17

  1. Avalyn Pharma Inc. AVLN$44.4 million
  2. CG Oncology Inc. CGON$35.1 million
  3. Seaport Therapeutics Inc. SPTX$23.9 million
  4. Palvella Therapeutics Inc. Ne PVLA$23.7 million
  5. Spyre Therapeutics Inc. SYRE$20.4 million
  6. Hemab Therapeutics Hldgs Inc. COAG$20.2 million
  7. Parabilis Medicines Inc. Com PBLS$13.7 million
  8. Aura Biosciences Inc. AURA$8.3 million

and 9 more in the table below

Added to 39

  1. Amgen Inc. AMGN+556,192 shares · +188%
  2. Insmed Inc. INSM+1.4 million shares · +13787%
  3. Gilead Sciences, Inc. GILD+988,893 shares · +85%
  4. Oruka Therapeutics Inc. ORKA+1.2 million shares · +227%
  5. United Therapeutics Corp. UTHR+186,438 shares · +8976%
  6. Bridgebio Pharma Inc. BBIO+1.2 million shares · +4587%
  7. Vaxcyte Inc. PCVX+781,238 shares · +66%
  8. Stryker Corp. SYK+51,224 shares · +24%

and 31 more in the table below

Trimmed 65

  1. Krystal Biotech, Inc. KRYS-404,255 shares · -84%
  2. Revolution Medicines, Inc. RVMD-496,442 shares · -32%
  3. Regeneron Pharmaceuticals, Inc. REGN-121,383 shares · -44%
  4. Alnylam Pharmaceuticals Inc ALNY-233,451 shares · -100%
  5. Ionis Pharmaceuticals Inc. IONS-846,407 shares · -47%
  6. Scholar Rock Holding Corporation SRRK-1.1 million shares · -32%
  7. Tango Therapeutics Inc. TNGX-1.7 million shares · -71%
  8. Vertex Pharmaceuticals Inc. VRTX-103,274 shares · -15%

and 57 more in the table below

Sold out of 24

  1. Edgewise Therapeutics Inc. EWTX$48.1 million last quarter
  2. Inspire Medical Systems, Inc. INSP$5.1 million last quarter
  3. Penumbra Inc. PEN$4.0 million last quarter
  4. Atrium Therapeutics Inc. RNA$3.5 million last quarter
  5. Masimo Corp. MASI$1.6 million last quarter
  6. Equinor ASA EQNR$741,581 last quarter
  7. ExxonMobil Holdings Corp. XOM$741,414 last quarter
  8. BP plc BP$735,268 last quarter

What it holds

CompanySharesValueOf its bookChange in shares
Amgen Inc. AMGN851,550$308.4 million6.49%+556,192
Vertex Pharmaceuticals Inc. VRTX578,634$287.4 million6.05%-103,274
argenx SE ARGX301,000$279.3 million5.88%-12,000
Gilead Sciences, Inc. GILD2,158,772$272.7 million5.74%+988,893
Revolution Medicines, Inc. RVMD1,048,014$196.3 million4.13%-496,442
Oruka Therapeutics Inc. ORKA1,657,190$157.7 million3.32%+1,150,182
Insmed Inc. INSM1,393,418$148.6 million3.13%+1,383,384
Scholar Rock Holding Corporation SRRK2,449,547$134.7 million2.83%-1,135,026
Nuvalent Inc. NUVL1,053,268$130.1 million2.74%no change
Viridian Therapeutics Inc. VRDN6,731,909$123.7 million2.60%+5,765
Relay Therapeutics Inc. RLAY6,185,970$115.7 million2.44%-1,609,272
Vaxcyte Inc. PCVX1,971,935$114.6 million2.41%+781,238
United Therapeutics Corp. UTHR188,515$102.1 million2.15%+186,438
Intuitive Surgical Inc. ISRG254,809$101.3 million2.13%-31,845
Regeneron Pharmaceuticals, Inc. REGN157,291$98.1 million2.06%-121,383
Crinetics Pharmaceuticals in CRNX2,620,000$98.0 million2.06%-660,000
Bridgebio Pharma Inc. BBIO1,189,506$88.6 million1.86%+1,164,129
Immunocore Hldgs PLC IMCR2,788,245$88.5 million1.86%-8,558
Abbott Laboratories ABT947,115$85.9 million1.81%-204,520
Stryker Corp. SYK268,461$84.5 million1.78%+51,224
Medtronic plc MDT994,233$77.8 million1.64%+36,904
Ionis Pharmaceuticals Inc. IONS972,258$77.1 million1.62%-846,407
Enliven Therapeutics Inc. ELVN1,490,000$75.6 million1.59%-830,867
Vera Therapeutics Inc. VERA1,710,808$73.4 million1.54%+37
Jade Biosciences Inc. JBIO3,057,996$67.9 million1.43%-443,506
Edwards Lifesciences Corp. EW739,234$66.9 million1.41%-100,217
Ultragenyx Pharmaceutical in RARE1,982,775$66.2 million1.39%-397,225
UnitedHealth Group Inc. UNH149,127$62.0 million1.30%+924
Dexcom Inc. DXCM822,489$55.4 million1.17%+33,723
Celldex Therapeutics Inc. CLDX1,200,000$44.7 million0.94%no change
Avalyn Pharma Inc. AVLN1,350,000$44.4 million0.94%new
Galecto Inc. DMRA1,618,846$42.1 million0.89%-679,154
Disc Medicine Inc. IRON560,000$41.0 million0.86%+100,686
Thermo Fisher Scientific Inc. TMO79,816$40.0 million0.84%+15,404
Boston Scientific Corp. BSX887,650$37.9 million0.80%-579,244
Eli Lilly & Co. LLY29,882$35.8 million0.75%-4,050
CG Oncology Inc. CGON493,596$35.1 million0.74%new
IDEXX Laboratories Inc. IDXX61,780$32.5 million0.68%-27,351
Resmed Inc. RMD148,195$28.9 million0.61%-11,151
Krystal Biotech, Inc. KRYS77,530$28.8 million0.61%-404,255
Monte Rosa Therapeutics Inc. GLUE1,190,000$28.8 million0.61%-60,000
Danaher Corp. DHR143,844$27.4 million0.58%-58,320
Johnson & Johnson JNJ103,280$26.2 million0.55%-15,822
Seaport Therapeutics Inc. SPTX1,100,000$23.9 million0.50%new
Palvella Therapeutics Inc. Ne PVLA155,000$23.7 million0.50%new
Align Technology Inc. ALGN139,680$23.6 million0.50%no change
Annexon Inc. ANNX4,100,016$23.4 million0.49%-1,057,274
Humana Inc. HUM58,398$23.2 million0.49%-6,100
Elevance Health, Inc. ELV56,449$21.8 million0.46%+3,931
Tango Therapeutics Inc. TNGX694,182$21.7 million0.46%-1,705,818
Steris plc STE99,877$21.0 million0.44%-1
Spyre Therapeutics Inc. SYRE229,931$20.4 million0.43%new
Hemab Therapeutics Hldgs Inc. COAG550,000$20.2 million0.43%new
Insulet Corp. PODD127,498$19.4 million0.41%-36,158
Cigna Group CI66,500$18.3 million0.39%-31,763
Glaukos Corp. GKOS128,667$18.0 million0.38%-17,036
CVS Health Corp. CVS169,366$17.5 million0.37%+80,003
Becton Dickinson & Co. BDX109,729$16.6 million0.35%-12,158
GE HealthCare Technologies Inc. GEHC252,744$16.2 million0.34%-164,143
LivaNova plc LIVN195,621$16.1 million0.34%+9,436
Centene Corp. CNC228,865$14.7 million0.31%-32,201
Merck & Co., Inc. MRK113,061$14.5 million0.31%-93,530
Cooper Companies, Inc. COO197,135$14.1 million0.30%-75,049
Parabilis Medicines Inc. Com PBLS500,000$13.7 million0.29%new
Teva Pharmaceutical Industries Ltd. TEVA345,899$11.7 million0.25%+95,817
Globus Medical Inc. GMED146,108$11.5 million0.24%-101,153
Procept Biorobotics Corp. PRCT502,286$11.3 million0.24%no change
Zimmer Biomet Holdings, Inc. ZBH126,707$10.9 million0.23%-28,864
Veeva Systems Inc. VEEV59,347$10.5 million0.22%+2,830
AbbVie Inc. ABBV40,476$10.2 million0.21%-53,091
10X Genomics Inc. TXG261,470$10.0 million0.21%-68,022
HCA Healthcare, Inc. HCA23,750$9.3 million0.19%-14,015
Aura Biosciences Inc. AURA1,166,667$8.3 million0.17%new
McKesson Corp. MCK9,625$7.3 million0.15%-12,727
Tenet Healthcare Corp. THC38,868$7.3 million0.15%+599
Protagonist Therapeutics, Inc. PTGX55,682$6.8 million0.14%+41,235
Natera Inc Com NTRA24,806$6.7 million0.14%-6,888
TransMedics Group, Inc. TMDX101,139$6.7 million0.14%no change
Molina Healthcare, Inc. MOH27,761$6.3 million0.13%new
Alkermes plc. ALKS120,243$6.3 million0.13%+111,373
Royalty Pharma PLC RPRX112,311$6.3 million0.13%+74,015
Waystar Holding Corp. WAY293,592$6.0 million0.13%+37,453
Privia Health Group, Inc. PRVA226,703$5.8 million0.12%no change
GMR Solutions Inc. GMRS333,333$5.2 million0.11%new
Neurocrine Biosciences Inc. NBIX24,037$4.1 million0.09%+19,391
Omada Health Inc. OMDA157,938$3.5 million0.07%no change
Kestra Med Technologies Ltd KMTS129,215$3.3 million0.07%+13,625
Medline Inc. MDLN82,153$3.2 million0.07%-54,482
Illumina, Inc. ILMN18,134$3.2 million0.07%-2,089
Beigene, Ltd ONC10,474$3.0 million0.06%+6,662
Newamsterdam Pharma Company NAMS86,994$2.9 million0.06%+59,333
Madrigal Pharmaceuticals Inc. MDGL4,675$2.5 million0.05%+1,635
SPDR S&P 500 SPY2,700$2.0 million0.04%no change
BioNTech SE BNTX21,229$2.0 million0.04%+378
Adaptive Biotechnologies Corporation ADPT89,439$1.9 million0.04%+13,258
Cytokinetics Inc. CYTK19,007$1.6 million0.03%+10,166
Alamar Biosciences Inc. ALMR55,738$1.5 million0.03%new
Phreesia Inc. PHR140,495$1.4 million0.03%+9,503
Mobia Med Inc. MOBI100,000$1.3 million0.03%new
Billiontoone Inc. BLLN10,554$1.3 million0.03%no change
Beta Bionics Inc BBNX72,152$1.1 million0.02%no change
Legend Biotech Corp. LEGN33,054$954,6000.02%-2,832
Pfizer Inc. PFE38,431$925,4180.02%-69,204
Abivax SA ABVX6,397$852,4640.02%+5,349
Encompass Health Corp. EHC6,951$702,6070.01%-2,878
Axsome Therapeutics Inc. AXSM2,689$658,1870.01%-492
Certara, Inc. CERT99,442$651,3450.01%no change
Agomab Therapeutics NV AGMB49,248$639,2390.01%-752
Praxis Precision Medicines I PRAX1,847$618,3570.01%+90
Apple Inc. AAPL1,768$540,5240.01%-1,552
Garmin Ltd. GRMN1,976$469,3790.01%+655
Denali Therapeutics Inc. DNLI17,766$456,9420.01%no change
Vaneck ETF Trust GDX5,750$433,8380.01%no change
Veradermics Inc MANE3,468$426,3560.01%new
Alphabet Inc. GOOGL907$395,6090.01%+593
Definium Therapeutics Inc. DFTX8,391$394,7130.01%new
Travere Therapeutics Inc. TVTX6,908$392,4430.01%-1,991
Amazon.com Inc. AMZN1,605$382,5360.01%+252
Halozyme Therapeutics, Inc. HALO4,348$340,3180.01%+491
Alnylam Pharmaceuticals Inc ALNY1,092$328,7250.01%-233,451
Crispr Therapeutics AG CRSP5,818$317,3140.01%+802
Structure Therapeutics Inc. GPCR4,762$255,5770.01%-2,041
Viatris Inc. VTRS15,778$250,5550.01%new
Mineralys Therapeutics Inc. MLYS8,753$236,1560.00%-20,621
Summit Therapeutics Inc. SMMT15,279$222,6150.00%-579
Cardinal Health Inc. CAH852$202,4010.00%-11
Cogent Biosciences Inc. COGT4,870$188,4690.00%new
Tempus Ai Inc. TEM3,213$186,1290.00%-1,737
Cencora, Inc. COR576$162,9960.00%-1,140
PTC Therapeutics, Inc. PTCT1,626$132,6330.00%-309
Caris Life Sciences Inc. CAI6,418$114,3690.00%no change
Rhythm Pharmaceuticals Inc. RYTM1,016$112,8060.00%no change
Arrowhead Pharmaceuticals, Inc. ARWR1,191$97,0780.00%-354
NVIDIA Corp. NVDA408$81,6370.00%no change
Labcorp Holdings Inc. LH280$78,4000.00%no change
Biogen Inc. BIIB338$73,0280.00%-3,315
Bristol-Myers Squibb Co. BMY1,216$70,0660.00%-15,822
Waters Corp. WAT179$67,1320.00%new
Microsoft Corp. MSFT172$64,1590.00%no change
IQVIA Holdings Inc. IQV293$56,6130.00%-447
Incyte Corp. INCY486$55,0930.00%no change
Mettler Toledo International Inc. MTD36$45,9900.00%no change
Agilent Technologies, Inc. A330$43,8340.00%-334
Qualcomm Inc. QCOM197$36,4040.00%no change
Zoetis Inc. ZTS390$28,0250.00%-143
Oracle Corp. ORCL191$27,9910.00%no change
Quest Diagnostics Inc. DGX131$27,7650.00%no change
Recursion Pharmaceuticals in RXRX4,627$16,9810.00%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before; the 24 it sold out of are in the box above.